Lexaria Bioscience Corp. (LEXX)

AI Score

Unlock

1.41

0.01 (0.71%)

At close: Apr 08, 2025, 12:50 PM

Dividends

No dividend history available for Lexaria Bioscience Corp..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

LEXX News

4 days ago · Lexaria Updates its Ongoing Human Study GLP-1-H24-4 - thenewswire.com
5 days ago · Lexaria's Human GLP-1 Study #5 Begins Dosing - accessnewswire.com
2 weeks ago · Lexarias' DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound - thenewswire.com
2 weeks ago · Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R) - accessnewswire.com
1 month ago · The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience - thenewswire.com
1 month ago · Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm - thenewswire.com
1 month ago · Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide - accessnewswire.com
1 month ago · Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy - accessnewswire.com
2 months ago · Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway - accessnewswire.com
2 months ago · Lexaria Releases Annual Letter from the CEO - accessnewswire.com